About Lisa Lewin

This author has not yet filled in any details.
So far Lisa Lewin has created 24 blog entries.

PRECISION VALUE & HEALTH NAMES DOUG FULLING PRESIDENT

2023-01-26T09:14:11-05:00News, Press Releases|

Proven Life Sciences Leader Takes Reins to Continue Rapid Growth and
Drive Next-Gen Commercialization Model

BETHESDA, MD (January 26, 2023) Precision Value & Health (PVH), today announces that Doug Fulling has joined as President. As the industry leader in delivering complementary, integrated and specialized capabilities across the commercialization continuum, Doug will be accountable for the overall strategy, organizational leadership, financial performance, and next-level growth of this market-leading commercial enterprise.

(more…)

New Tech on the Rise: The Future of Cell and Gene Therapies Is Here

2023-01-19T07:10:40-05:00Cell & Gene Therapy|

Recent headlines suggest that the biotech industry as a whole is experiencing a downturn, yet in spite of this narrative the momentum for advanced therapies continues to persevere. Many companies in the cell and gene therapy space are dedicated to bringing these novel therapies to the patients who need them. In this article for PM360 Magazine, Precision’s Anshul Mangal explores the breakthroughs taking place in autologous cell therapies, non-viral delivery methods, and gene editing technologies that may improve patient access for life-saving treatments.

(more…)

Precision for Medicine Accelerating Precision Oncology with Next Generation Screening to Support New Cancer Diagnostics

2022-11-07T20:22:58-05:00News, Press Releases|

BETHESDA, MD — Nov. 3, 2022 — Precision for Medicine, the first biomarker-driven clinical research organization (CRO) supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively, announces the culmination of a groundbreaking Next Generation Sequencing (NGS) initiative which improved the accuracy and speed of identifying cancer mutations in solid tumors, allowing researchers and manufacturers to develop patient-specific diagnostics for improved clinical outcomes.

(more…)

Load More Posts